These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Naphthoquinone-dopamine hybrids disrupt α-synuclein fibrils by their intramolecular synergistic interactions with fibrils and display a better effect on fibril disruption. Zhou Y; Yao Y; Yang Z; Tang Y; Wei G Phys Chem Chem Phys; 2023 May; 25(20):14471-14483. PubMed ID: 37190853 [TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646 [TBL] [Abstract][Full Text] [Related]
13. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3. Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y J Biol Chem; 2021; 296():100663. PubMed ID: 33862084 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945 [TBL] [Abstract][Full Text] [Related]
15. A RaPID Macrocyclic Peptide That Inhibits the Formation of α-Synuclein Amyloid Fibrils. Ikenoue T; Oono M; So M; Yamakado H; Arata T; Takahashi R; Kawata Y; Suga H Chembiochem; 2023 Jun; 24(12):e202300320. PubMed ID: 37186077 [TBL] [Abstract][Full Text] [Related]
16. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth. Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724 [TBL] [Abstract][Full Text] [Related]
17. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells. Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946 [TBL] [Abstract][Full Text] [Related]
18. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
19. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease. Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048 [TBL] [Abstract][Full Text] [Related]